Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABCL | AZN | AMGN | GILD | VRTX |
| Company | Abcellera Biologics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 9.42 | 162.06 | 415.52 | 132.68 | 525.02 |
| High | 10.08 | 162.26 | 421.79 | 135.64 | 531.10 |
| Low | 9.02 | 160.00 | 413.04 | 132.01 | 522.01 |
| Last | 10.19 | 160.49 | 413.89 | 134.64 | 529.62 |
| Change | +0.85 | -1.42 | -3.31 | +1.58 | +5.71 |
| Percent Change | +9.10% | -0.88% | -0.79% | +1.19% | +1.09% |
| Volume | 4,749,330 | 649,875 | 240,162 | 906,938 | 174,490 |
| 20-Day Average Volume | 7,048,606 | 3,753,053 | 2,625,385 | 6,765,015 | 1,345,095 |
| Previous | 9.34 | 161.91 | 417.20 | 133.06 | 523.91 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 6.28 | 166.22 | 384.73 | 132.25 | 485.59 |
| 20-Day Raw Stochastic | 95.43% | 34.35% | 89.70% | 51.31% | 77.38% |
| 20-Day Relative Strength | 73.40 | 39.99 | 69.42 | 54.03 | 67.10 |
| Weighted Alpha | +85.58 | -7.19 | +44.59 | +11.74 | +36.82 |
| Today's Opinion | 88% Buy | 100% Sell | 100% Buy | 24% Buy | 100% Buy |
| Yesterday's Opinion | 88% Buy | 100% Sell | 100% Buy | 8% Buy | 100% Buy |
| Last Month's Opinion | 88% Buy | 88% Sell | 72% Buy | 24% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +60.59% since 08/04/26 | +3.35% since 08/04/26 | +6.35% since 08/04/26 | -0.72% since 08/04/26 | +10.26% since 08/04/26 |
| Low | 5.62 on 08/06/26 | 159.75 on 08/06/26 | 391.00 on 08/05/26 | 129.02 on 08/06/26 | 479.02 on 08/05/26 |
| High | 10.01 on 08/10/26 | 164.45 on 08/05/26 | 421.79 on 08/11/26 | 137.80 on 08/05/26 | 546.17 on 08/10/26 |
| 1-Month | |||||
| %Chg | +43.82% since 07/10/26 | -6.28% since 07/10/26 | +14.15% since 07/10/26 | +3.43% since 07/10/26 | +8.74% since 07/10/26 |
| Low | 4.98 on 07/28/26 | 153.41 on 08/03/26 | 353.95 on 07/15/26 | 127.61 on 07/23/26 | 465.00 on 07/23/26 |
| High | 10.01 on 08/10/26 | 175.04 on 07/29/26 | 421.79 on 08/11/26 | 140.61 on 07/17/26 | 546.17 on 08/10/26 |
| 3-Month | |||||
| %Chg | +86.29% since 05/11/26 | -11.56% since 05/11/26 | +25.85% since 05/11/26 | +0.57% since 05/11/26 | +21.29% since 05/11/26 |
| Low | 3.94 on 05/19/26 | 153.41 on 08/03/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 10.01 on 08/10/26 | 196.41 on 07/02/26 | 421.79 on 08/11/26 | 140.61 on 07/17/26 | 546.17 on 08/10/26 |
| 6-Month | |||||
| %Chg | +212.46% since 02/11/26 | -21.45% since 02/11/26 | +13.15% since 02/11/26 | -13.81% since 02/11/26 | +14.43% since 02/11/26 |
| Low | 2.93 on 02/12/26 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 10.01 on 08/10/26 | 212.71 on 02/18/26 | 421.79 on 08/11/26 | 156.95 on 02/13/26 | 546.17 on 08/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,863,747 | 251,107,520 | 225,551,680 | 164,988,400 | 132,970,968 |
| Shares Outstanding, K | 306,611 | 1,550,908 | 540,632 | 1,239,955 | 253,805 |
| Annual Sales, $M | 75,130,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income, $M | -146,410,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Qtr Sales, $M | 4,050,000 | 15,384,000,000 | 10,054,000,000 | 7,803,000,000 | 3,333,900,000 |
| Last Qtr Income, $M | -55,430,000 | 2,507,000,000 | 2,375,000,000 | -10,496,000,000 | 1,099,800,000 |
| 60-Month Beta | 1.20 | 0.26 | 0.41 | 0.32 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 08/05/26 | 2.63 on 07/27/26 | 6.29 on 08/04/26 | -6.75 on 08/04/26 | 4.73 on 08/03/26 |
| Latest Earnings Date | 11/05/26 | 11/05/26 | 11/03/26 | 10/29/26 | 11/02/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividend Date | N/A | 02/20/26 | 08/21/26 | 09/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.62 | 18.37 | 0.00 | 29.15 |